Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura

NCT00907751 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Thrombotic Thrombocytopenic Purpura

Interventions

DRUG: rituximab

Sponsor

Assistance Publique - Hôpitaux de Paris